amypad_logoAmyloid imaging to prevent Alzheimer’s Disease

The Amyloid imaging to prevent Alzheimer’s Disease (AMYPAD) project aims at studying the onset, dynamics, and clinical relevance of brain β-amyloid in the spectrum from normal aging, through subjective cognitive decline towards mild cognitive impairment and ultimately dementia due to Alzheimer’s Disease (AD), studying the value of β-amyloid imaging as a diagnostic and therapeutic marker for AD.

The AMYPAD project has an initial budget of €27.33M distributed across a total of 15 partners from the private and academic sectors, mainly sponsored by the European Union’s Horizon 2020 research and innovation programme and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative 2 Joint Undertaking.

For more information, contact info@amypad.eu or check out www.amypad.eu

Related Entries